Analysis of a cohort of prostate patients treated with HDR mono-brachytherapy.

Abstract

The aim of this study is to perform volumetric and basic radiobiological analyses using the database on prostate patients treated by HDR brachytherapy in our institution during the period 2011-2016. Real-time ultrasound based technique was used, with Oncentra Prostate planning software. The whole period was divided into two sub-periods, according to the 100% dose per fraction, which was 10.5Gy during the first period (2011-2012), and 11Gy during the second period (2013-2016), for each of the three fractions. The follow up time varied from 19 to 81months, with a median of 45months and a mean of 47months. The uniformity of the treatment technique for both periods is investigated. Tumour Control Probability (TCP) values for the expected local control are calculated according to a population phenomenological TCP model for different values of the α/β ratio. The calculations are based on the obtained averaged Dose Volume Histograms for the two investigated sub-periods. 74 patients were treated in total. Local control failure is observed in 5 cases, which corresponds to an observed TCP = 93.2%. The comparison of the calculated population average DVH with the DVHs of the cases with local control failure shows that in 4 of them, doses higher than average were delivered to the prostate. It is shown that the uniformity of the treatment was improved during the second sub-period. A possible explanation of the observed failures may be that these cases exhibit inherenttumour cell radio-resistance higher than average. Our radiobiological analysis indicates a α/β ratio value somewhat higher than the one currently accepted. The value of the prostate α/β ratio is estimated to be in the range of [3.5-6] Gy.